🇺🇸 lorazepam (Ativan) in United States

42 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 42

Most-reported reactions

1. Nausea — 8 reports (19.05%)
2. Diarrhoea — 7 reports (16.67%)
3. Abdominal Distension — 4 reports (9.52%)
4. Dyspnoea — 4 reports (9.52%)
5. Vomiting — 4 reports (9.52%)
6. Decreased Appetite — 3 reports (7.14%)
7. Infusion Related Reaction — 3 reports (7.14%)
8. Subdural Haematoma — 3 reports (7.14%)
9. Unresponsive To Stimuli — 3 reports (7.14%)
10. Weight Decreased — 3 reports (7.14%)

Source database →

Frequently asked questions

Is lorazepam (Ativan) approved in United States?

lorazepam (Ativan) does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for lorazepam (Ativan) in United States?

National Institute on Alcohol Abuse and Alcoholism (NIAAA) is the originator. The local marketing authorisation holder may differ — check the official source linked above.